Caplan - Canada at the Summit - (Page 16)

new KNOWLEDGE for a new economy CANADA AT THE SUM MIT BIOTECH to the RESCUE Established in early 2008, PlantForm Corp. is a biotechnology company that leverages new platform technology to produce vaccines and antibodies in tobacco plants more quickly and cheaply than by traditional processes. Currently under development is a generic version of the breast cancer drug Herceptin whose treatment price tag today is estimated to be $50,000. “The technology that we have licensed from the University of Guelph is the key to having the product available by 2014”, says Donald Stewart, the firm’s president & CEO. “By using the green fermentation process within tobacco plants, we will be able to produce the drug at about 10 per cent of the cost now incurred in conventional pharmaceutical laboratories.” www.newknowledge.ca UNIVERSITY OF GUELPH http://www.perimeterinstitute.ca http://www.perimeterinstitute.ca http://www.cisco.com/go/netacad/can http://www.newknowledge.ca http://www.newknowledge.ca

Table of Contents for the Digital Edition of Caplan - Canada at the Summit

Caplan - Canada at the Summit